Published in Toxicol In Vitro on February 01, 2005
T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest (2012) 2.66
An ex vivo swine tracheal organ culture for the study of influenza infection. Influenza Other Respir Viruses (2010) 0.92
Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components. Innate Immun (2013) 0.88
Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J Mol Med (Berl) (2014) 0.87
Taste receptors in innate immunity. Cell Mol Life Sci (2014) 0.86
Interfacial sensing by alveolar type II cells: a new concept in lung physiology? Am J Physiol Cell Physiol (2011) 0.79
Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance. PLoS One (2016) 0.79
Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposis. PLoS One (2014) 0.78
In vitro culturing of ciliary respiratory cells--a model for studies of genetic diseases. J Appl Genet (2010) 0.78
Enhancing effect of borneol and muscone on geniposide transport across the human nasal epithelial cell monolayer. PLoS One (2014) 0.78
Evaluation of nasal epithelium sampling as a tool in the preclinical development of siRNA-based therapeutics for asthma. J Cell Mol Med (2013) 0.77
Expression of dermcidin in human sinonasal secretions. Int Forum Allergy Rhinol (2016) 0.75
Taste Receptors Mediate Sinonasal Immunity and Respiratory Disease. Int J Mol Sci (2017) 0.75
Taste Receptors: Regulators of Sinonasal Innate Immunity. Laryngoscope Investig Otolaryngol (2016) 0.75
A novel method for banking stem cells from human exfoliated deciduous teeth: lentiviral TERT immortalization and phenotypical analysis. Stem Cell Res Ther (2016) 0.75
A role for airway taste receptor modulation in the treatment of upper respiratory infections. Expert Rev Respir Med (2016) 0.75
Bacterial d-amino acids suppress sinonasal innate immunity through sweet taste receptors in solitary chemosensory cells. Sci Signal (2017) 0.75
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci (1996) 3.83
Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J (2009) 3.05
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68
IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest (2001) 1.60
Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet (2000) 1.57
The potential use of cyclodextrins in parenteral formulations. J Parenter Sci Technol (1989) 1.43
Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metab Dispos (2002) 1.33
Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice. Antimicrob Agents Chemother (1998) 1.26
Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica (2010) 1.22
Aneurysmal bone cyst of the nose with 17p13 involvement. Virchows Arch (2001) 1.21
Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci (2000) 1.21
Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells. Hum Mol Genet (1997) 1.15
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci (2001) 1.14
Sudden blindness in a child: presenting symptom of a sphenoid sinus mucocele. Br J Ophthalmol (1992) 1.10
Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes. Eur J Hum Genet (2000) 1.00
Serological identification of viral antigens after electrophoretic transfer. J Immunol Methods (1981) 0.98
Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int J Pharm (2007) 0.98
Axonemal beta heavy chain dynein DNAH9: cDNA sequence, genomic structure, and investigation of its role in primary ciliary dyskinesia. Genomics (2001) 0.97
The prevalence of humoral immunodeficiency in refractory rhinosinusitis: a retrospective analysis. B-ENT (2006) 0.96
Simulated intestinal fluid as transport medium in the Caco-2 cell culture model. Int J Pharm (2002) 0.94
Multidrug resistance-associated protein 2 (MRP2) affects hepatobiliary elimination but not the intestinal disposition of tenofovir disoproxil fumarate and its metabolites. Xenobiotica (2006) 0.92
Use of azo polymers for colon-specific drug delivery. J Pharm Sci (1997) 0.92
Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2). Pharm Res (1997) 0.90
Correlations between ciliary structure and ciliary function. Acta Otorhinolaryngol Belg (2000) 0.90
Cerebrospinal fluid proteins in neurology. Int Rev Neurobiol (1984) 0.90
Site-specific, sustained release of drugs to the brain. Science (1981) 0.89
Cellular composition of primary cultures from cerebral cortex, striatum, hippocampus, brainstem and cerebellum. Brain Res (1984) 0.89
Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA. Int J Pharm (1999) 0.88
Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1. AIDS (2001) 0.88
Species-dependent and site-specific intestinal metabolism of ester prodrugs. Int J Pharm (2000) 0.87
Structural studies of loteprednol etabonate and other analogs of prednisolone using NMR techniques. Steroids (1996) 0.87
Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. J Pharm Sci (2009) 0.87
Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology (2010) 0.87
Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro. J Antimicrob Chemother (2000) 0.86
New bis(SATE) prodrug of AZT 5'-monophosphate: in vitro anti-HIV activity, stability, and potential oral absorption. J Pharm Sci (2001) 0.86
Problems of delivery of drugs to the brain. Pharmacol Ther (1982) 0.86
Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles. Int J Pharm (2006) 0.86
In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies. J Pharm Pharmacol (2001) 0.85
Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int J Pharm (2000) 0.85
Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy (2006) 0.84
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm (2004) 0.84
Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy (2010) 0.84
Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose. J Control Release (2000) 0.84
Minimally invasive endoscopic management of malignant sinonasal tumours. Acta Otorhinolaryngol Belg (2000) 0.84
Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. B-ENT (2008) 0.83
Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study. Pharm Res (1999) 0.83
Mucociliary transport using 99mTc-albumin colloid: a reliable screening test for primary ciliary dyskinesia. Thorax (2005) 0.83
Negative impact of occupational exposure on surgical outcome in patients with rhinosinusitis. Allergy (2012) 0.83
Otorrhea during transtympanal ventilation. Am J Otol (1988) 0.83
Short term effects of antibiotics (Zinnat) after endoscopic sinus surgery. Acta Otorhinolaryngol Belg (2000) 0.83
Genetic evidence for a role of IL33 in nasal polyposis. Allergy (2009) 0.83
Transfer of phosphatidylcholine facilitated by a component of human plasma. Biochim Biophys Acta (1978) 0.83
Adenoids and tonsils, indications for surgery and immunological consequences of surgery. Acta Otorhinolaryngol Belg (2000) 0.82
A fatality involving U4Euh, a cyclic derivative of phenylpropanolamine. J Forensic Sci (1988) 0.82
Comparing the microdebrider and standard instruments in endoscopic sinus surgery: a double-blind randomised study. B-ENT (2007) 0.82
Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781. Int J Pharm (2002) 0.82
Adenocarcinomas of the sinonasal tract: current opinion. B-ENT (2011) 0.82
Situs inversus totalis and primary ciliary dyskinesia (Kartagener's syndrome) in a horse. J Vet Intern Med (2008) 0.82
Chronic rhinosinusitis in cystic fibrosis (mucoviscidosis). Acta Otorhinolaryngol Belg (1997) 0.81
Endoscopic septal spur resection in combination with endoscopic sinus surgery. Acta Otorhinolaryngol Belg (1998) 0.81
The use of polymer-based electrospun nanofibers containing amorphous drug dispersions for the delivery of poorly water-soluble pharmaceuticals. Pharmazie (2004) 0.81
Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome. J Neurol (1986) 0.81
Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility. Pharmazie (2007) 0.81
Potential of amorphous microporous silica for ibuprofen controlled release. Int J Pharm (2010) 0.81
Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin Chim Acta (1986) 0.80
Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers. Pharm Res (1998) 0.80
The Waldeyer's ring. Acta Otorhinolaryngol Belg (2000) 0.80
Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates. Pharmazie (2008) 0.80
Peroxidase-catalyzed S-oxygenation: mechanism of oxygen transfer for lactoperoxidase. Biochemistry (1991) 0.80
Inulin hydrogels as carriers for colonic drug targeting: I. Synthesis and characterization of methacrylated inulin and hydrogel formation. Pharm Res (1997) 0.80
Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. Eur J Pharm Sci (2000) 0.80
Mucociliary clearance following segmental tracheal reversal. Laryngoscope (1996) 0.80
Effects of pharmaceutical compounds on ciliary beating in human nasal epithelial cells: a comparative study of cell culture models. Pharm Res (1999) 0.79
Glial cells identified by anti-alpha-albumin (anti-GFA) in human pineal gland. J Neurochem (1982) 0.79
Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins. J Parenter Sci Technol (1990) 0.79
Tonsillectomy as a day-case surgery: a safe procedure? B-ENT (2006) 0.79
Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sci (1988) 0.79
Stability prediction of amorphous benzodiazepines by calculation of the mean relaxation time constant using the Williams-Watts decay function. Eur J Pharm Biopharm (1999) 0.79
Identification of several forms of the glial fibrillary acidic protein, or alpha-albumin, by a specific monoclonal antibody. J Neurochem (1984) 0.79
Characterization of glassy itraconazole: a comparative study of its molecular mobility below T(g) with that of structural analogues using MTDSC. Int J Pharm (2001) 0.79
High-performance liquid chromatographic assay of a central nervous system (CNS)-directed estradiol chemical delivery system and its application after intravenous administration to rats. Pharm Res (1988) 0.79
Isolation, in silico characterization and chromosomal localization of a group of cDNAs from ciliated epithelial cells after in vitro ciliogenesis. Genome Biol (2001) 0.79
Rhinitis/Bronchopneumonia syndrome in Irish Wolfhounds. J Vet Intern Med (2003) 0.78
Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism. Drug Metab Dispos (2000) 0.78
Dexamethasone-induced apoptosis of freshly isolated human nasal epithelial cells concomitant with abrogation of IL-8 production. Rhinology (2010) 0.78
Use of ciliogenesis in the diagnosis of primary ciliary dyskinesia in a dog. J Am Vet Med Assoc (2000) 0.78
Characterization of self-assembling copolymers in aqueous solutions using Electron Paramagnetic Resonance and Fluorescence spectroscopy. J Control Release (2006) 0.78
In vitro transport and uptake of protohypericin and hypericin in the Caco-2 model. Int J Pharm (1999) 0.78
In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. J Pharm Sci (2000) 0.78
Unique approach to secondary cleft-lip rhinoplasty in facial plastic surgery. B-ENT (2010) 0.78
Surgery of inverted papillomas under endoscopic control. Acta Otorhinolaryngol Belg (2000) 0.78
Chronic maxillary atelectasis. B-ENT (2005) 0.77
Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency. Int J Pharm (2003) 0.77
Malignant ectomesenchymoma of the paranasal sinuses with proptosis. B-ENT (2011) 0.77
Sustained brain-specific delivery of estradiol causes long-term suppression of luteinizing hormone secretion. J Med Chem (1986) 0.77